These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 8581860)

  • 41. Strategies for the control and prevention of bovine viral diarrhea virus.
    Brock KV
    Vet Clin North Am Food Anim Pract; 2004 Mar; 20(1):171-80. PubMed ID: 15062481
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The Occurrence of a Commercial N
    Wernike K; Michelitsch A; Aebischer A; Schaarschmidt U; Konrath A; Nieper H; Sehl J; Teifke JP; Beer M
    Viruses; 2018 May; 10(5):. PubMed ID: 29783722
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cytotoxic T-lymphocyte responses in cattle infected with bovine viral diarrhea virus.
    Beer M; Wolf G; Pichler J; Wolfmeyer A; Kaaden OR
    Vet Microbiol; 1997 Oct; 58(1):9-22. PubMed ID: 9451457
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Priming Cross-Protective Bovine Viral Diarrhea Virus-Specific Immunity Using Live-Vectored Mosaic Antigens.
    Lokhandwala S; Fang X; Waghela SD; Bray J; Njongmeta LM; Herring A; Abdelsalam KW; Chase C; Mwangi W
    PLoS One; 2017; 12(1):e0170425. PubMed ID: 28099492
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Response of cattle persistently infected with noncytopathic bovine viral diarrhea virus to vaccination for bovine viral diarrhea and to subsequent challenge exposure with cytopathic bovine viral diarrhea virus.
    Bolin SR; McClurkin AW; Cutlip RC; Coria MF
    Am J Vet Res; 1985 Dec; 46(12):2467-70. PubMed ID: 3002214
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Virus neutralising antibodies against 22 bovine viral diarrhoea virus isolates in vaccinated calves.
    Hamers C; Di Valentin E; Lecomte C; Lambot M; Joris E; Genicot B; Pastoret PP
    Vet J; 2002 Jan; 163(1):61-7. PubMed ID: 11749137
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparison of three commercial vaccines for preventing persistent infection with bovine viral diarrhea virus.
    Rodning SP; Marley MS; Zhang Y; Eason AB; Nunley CL; Walz PH; Riddell KP; Galik PK; Brodersen BW; Givens MD
    Theriogenology; 2010 May; 73(8):1154-63. PubMed ID: 20181385
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Bovine viral diarrhea control in Russian Federation].
    Guliukin MI; Iurov KP; Glotov AG; Donchenko NA
    Vopr Virusol; 2013; 58(6):13-8. PubMed ID: 24772640
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Immune response to bovine viral diarrhea virus--looking at newly defined targets.
    Chase CC; Thakur N; Darweesh MF; Morarie-Kane SE; Rajput MK
    Anim Health Res Rev; 2015 Jun; 16(1):4-14. PubMed ID: 26050567
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Bovine viral diarrhoea virus (BVDV) diversity and vaccination. A review.
    Kalaycioglu AT
    Vet Q; 2007 Jun; 29(2):60-7. PubMed ID: 17663212
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Production of a highly immunogenic subunit ISCOM vaccine against Bovine Viral Diarrhea Virus.
    Kamstrup S; Roensholt L; Jensen MH; Dalsgaard K
    Vaccine; 1999 Mar; 17(9-10):1057-64. PubMed ID: 10195615
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Protection of the bovine fetus from bovine viral diarrhoea virus by means of a new inactivated vaccine.
    Brownlie J; Clarke MC; Hooper LB; Bell GD
    Vet Rec; 1995 Jul; 137(3):58-62. PubMed ID: 8533232
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Evaluation of three experimental bovine viral diarrhea virus killed vaccines adjuvanted with combinations of Quil A cholesterol and dimethyldioctadecylammonium (DDA) bromide.
    Ridpath JF; Dominowski P; Mannan R; Yancey R; Jackson JA; Taylor L; Mediratta S; Eversole R; Mackenzie CD; Neill JD
    Vet Res Commun; 2010 Dec; 34(8):691-702. PubMed ID: 20872289
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Bovilis BVD: a potent immunogen vaccine].
    Kuijk H
    Tijdschr Diergeneeskd; 2004 Mar; 129(5):167. PubMed ID: 15032043
    [No Abstract]   [Full Text] [Related]  

  • 55. Efficacy of bovine viral diarrhea vaccine used in Japan against bovine viral diarrhea virus type 2 strain 890.
    Shimazaki T; Nakamura S; Taguchi K; Inoue Y
    J Vet Med Sci; 2003 Feb; 65(2):263-6. PubMed ID: 12655125
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A case report: evidence for type 2 bovine viral diarrhea virus (BVDV)-associated disease in beef herds vaccinated with a modified-live type 1 BVDV vaccine.
    Van Campen H; Vorpahl P; Huzurbazar S; Edwards J; Cavender J
    J Vet Diagn Invest; 2000 May; 12(3):263-5. PubMed ID: 10826842
    [No Abstract]   [Full Text] [Related]  

  • 57. A novel subunit ISCOM vaccine against bovine virus diarrhoea virus.
    Kamstrup S; Rønsholt L; Jensen MH; Dalsgaard K
    Rev Sci Tech; 1992 Sep; 11(3):873-7. PubMed ID: 1335308
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Characterization of protection against systemic infection and disease from experimental bovine viral diarrhea virus type 2 infection by use of a modified-live noncytopathic type 1 vaccine in calves.
    Kelling CL; Hunsaker BD; Steffen DJ; Topliff CL; Eskridge KM
    Am J Vet Res; 2007 Jul; 68(7):788-96. PubMed ID: 17605616
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Point mutations in an infectious bovine viral diarrhoea virus type 2 cDNA transcript that yields an attenuated and protective viral progeny.
    Dehan P; Couvreur B; Hamers C; Lewalle P; Thiry E; Kerkhofs P; Pastoret PP
    Vaccine; 2005 Jul; 23(33):4236-46. PubMed ID: 16005739
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Enhanced neutralising antibody response to bovine viral diarrhoea virus (BVDV) induced by DNA vaccination in calves.
    R El-Attar LM; Thomas C; Luke J; A Williams J; Brownlie J
    Vaccine; 2015 Jul; 33(32):4004-12. PubMed ID: 26079613
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.